# Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent

> **NCT01233453** · PHASE4 · UNKNOWN · sponsor: **Maasstad Hospital** · enrollment: 2700 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** the everolimus eluting ® stent
- **DEVICE:** the Biolimus A9 eluting NOBORI® stent

## Key facts

- **NCT ID:** NCT01233453
- **Lead sponsor:** Maasstad Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2012-05
- **Final completion:** 2015-12
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2014-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233453, "Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01233453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*